Get In Touch
LENVATINIB
EISAI PHARMACEUTICALS INDIA PVT LTD
Advanced Thyroid Cancer
10 CAPSULE(s) IN A STRIP
Capsule
Lenvima 4 mg Capsule contains the active ingredient Lenvatinib, a targeted anticancer medicine that belongs to the class of tyrosine kinase inhibitors (TKIs). It is primarily used in the treatment of advanced or progressive thyroid cancer, especially in cases where radioactive iodine therapy is no longer effective. In addition, Lenvima is also prescribed for patients with unresectable liver cancer (hepatocellular carcinoma) who are not suitable candidates for surgery. This medicine works by blocking specific proteins that promote tumor growth and blood supply, thereby helping to slow down cancer progression and improve treatment outcomes. Thyroid cancers such as anaplastic thyroid carcinoma, often seen in older adults, may present with symptoms like a hard swelling in the neck and voice changes, while liver cancer is commonly linked to conditions like cirrhosis or chronic hepatitis B infection.
Before starting treatment, it is important for patients to inform their doctor about any allergies to Lenvatinib or related components, as the medication should not be used in such cases. Lenvima may also affect wound healing and increase the risk of bleeding, so patients should inform their dentist or surgeon before undergoing any dental or surgical procedures. Regular medical monitoring is essential during treatment to ensure safety and effectiveness. The price of Lenvima 4 mg Capsule in India may vary depending on the retailer, and patients can explore options to buy Lenvima online in India at affordable prices through trusted platforms. Always consult a healthcare professional before starting or purchasing this medication to ensure it is suitable for your condition.
Lenvima 4 mg Capsule is a targeted anticancer medicine used to treat multiple types of advanced cancers, including advanced thyroid cancer, liver cancer (hepatocellular carcinoma), kidney cancer, and endometrial cancer. It works by blocking specific proteins that help cancer cells grow and form new blood vessels, thereby slowing tumor growth and spread. When used as prescribed, Lenvima helps improve disease control, delay cancer progression, and enhance overall survival outcomes, making it an important treatment option for patients with advanced or difficult-to-treat cancers.
Like other anticancer medicines, Lenvima 4 mg Capsule may cause side effects that can range from mild to serious depending on the patient’s response to treatment.
Although rare, these require immediate medical attention:
If you experience any severe or unusual symptoms, seek immediate medical attention.
Do not use it if you are allergic to Lenvatinib or any of its ingredients.
May cause high blood pressure; regular monitoring is required during treatment.
Use with caution in patients with liver, kidney, or heart problems.
Can increase the risk of bleeding and delayed wound healing; inform your doctor before any surgery or dental procedure.
May cause protein in urine; periodic urine tests may be needed.
Not recommended during pregnancy; use effective contraception during treatment and for some time after the last dose.
Inform your doctor about all medications, supplements, or medical conditions before starting therapy.
Store at room temperature (below 30°C).
Keep in a cool, dry place away from direct sunlight and moisture.
Lenvima 4 mg Capsule is used to treat advanced thyroid cancer, liver cancer, kidney cancer, and endometrial cancer, especially in patients who are not suitable for surgery or other standard treatments.
Lenvima contains Lenvatinib, a tyrosine kinase inhibitor that blocks proteins involved in tumor growth and blood vessel formation (angiogenesis), helping to slow cancer progression.
Lenvima does not cure cancer, but it helps control tumor growth, delay disease progression, and improve survival outcomes in patients with advanced cancers.
Doctors may regularly monitor blood pressure, liver and kidney function, urine protein levels, and overall health to ensure safe and effective treatment.
Serious risks include severe hypertension, bleeding, heart problems, liver dysfunction, and delayed wound healing, which require immediate medical attention.
Yes, Lenvima may be used alone or in combination with other treatments, depending on the type of cancer and treatment plan.
Lenvima is not recommended during pregnancy, as it may harm the unborn baby. Breastfeeding should also be avoided during treatment.
Treatment duration depends on the patient’s condition, but it is usually continued until disease progression or unacceptable side effects occur, as advised by the doctor.
Lenvima 4 mg Capsule contains the active ingredient Lenvatinib, a targeted anticancer medicine that belongs to the class of tyrosine kinase inhibitors (TKIs). It is primarily used in the treatment of advanced or progressive thyroid cancer, especially in cases where radioactive iodine therapy is no longer effective. In addition, Lenvima is also prescribed for patients with unresectable liver cancer (hepatocellular carcinoma) who are not suitable candidates for surgery. This medicine works by blocking specific proteins that promote tumor growth and blood supply, thereby helping to slow down cancer progression and improve treatment outcomes. Thyroid cancers such as anaplastic thyroid carcinoma, often seen in older adults, may present with symptoms like a hard swelling in the neck and voice changes, while liver cancer is commonly linked to conditions like cirrhosis or chronic hepatitis B infection.
Before starting treatment, it is important for patients to inform their doctor about any allergies to Lenvatinib or related components, as the medication should not be used in such cases. Lenvima may also affect wound healing and increase the risk of bleeding, so patients should inform their dentist or surgeon before undergoing any dental or surgical procedures. Regular medical monitoring is essential during treatment to ensure safety and effectiveness. The price of Lenvima 4 mg Capsule in India may vary depending on the retailer, and patients can explore options to buy Lenvima online in India at affordable prices through trusted platforms. Always consult a healthcare professional before starting or purchasing this medication to ensure it is suitable for your condition.
Lenvima 4 mg Capsule is a targeted anticancer medicine used to treat multiple types of advanced cancers, including advanced thyroid cancer, liver cancer (hepatocellular carcinoma), kidney cancer, and endometrial cancer. It works by blocking specific proteins that help cancer cells grow and form new blood vessels, thereby slowing tumor growth and spread. When used as prescribed, Lenvima helps improve disease control, delay cancer progression, and enhance overall survival outcomes, making it an important treatment option for patients with advanced or difficult-to-treat cancers.
Like other anticancer medicines, Lenvima 4 mg Capsule may cause side effects that can range from mild to serious depending on the patient’s response to treatment.
Although rare, these require immediate medical attention:
If you experience any severe or unusual symptoms, seek immediate medical attention.
Do not use it if you are allergic to Lenvatinib or any of its ingredients.
May cause high blood pressure; regular monitoring is required during treatment.
Use with caution in patients with liver, kidney, or heart problems.
Can increase the risk of bleeding and delayed wound healing; inform your doctor before any surgery or dental procedure.
May cause protein in urine; periodic urine tests may be needed.
Not recommended during pregnancy; use effective contraception during treatment and for some time after the last dose.
Inform your doctor about all medications, supplements, or medical conditions before starting therapy.
Store at room temperature (below 30°C).
Keep in a cool, dry place away from direct sunlight and moisture.
Lenvima 4 mg Capsule is used to treat advanced thyroid cancer, liver cancer, kidney cancer, and endometrial cancer, especially in patients who are not suitable for surgery or other standard treatments.
Lenvima contains Lenvatinib, a tyrosine kinase inhibitor that blocks proteins involved in tumor growth and blood vessel formation (angiogenesis), helping to slow cancer progression.
Lenvima does not cure cancer, but it helps control tumor growth, delay disease progression, and improve survival outcomes in patients with advanced cancers.
Doctors may regularly monitor blood pressure, liver and kidney function, urine protein levels, and overall health to ensure safe and effective treatment.
Serious risks include severe hypertension, bleeding, heart problems, liver dysfunction, and delayed wound healing, which require immediate medical attention.
Yes, Lenvima may be used alone or in combination with other treatments, depending on the type of cancer and treatment plan.
Lenvima is not recommended during pregnancy, as it may harm the unborn baby. Breastfeeding should also be avoided during treatment.
Treatment duration depends on the patient’s condition, but it is usually continued until disease progression or unacceptable side effects occur, as advised by the doctor.
Sourced from Manufacturers
Air Express Delivery
Trusted Medicines
Get Up to 85% Off
